FDA approves Incyte's treatment for chronic graft-versus-host disease

[cafead]

via The U.S. Food and Drug Administration on Wednesday approved Incyte's (INCY.O) treatment for chronic graft-versus-host disease (GvHD), a potentially fatal complication that could occur after a stem cell transplant.

article source